|
 |
Huntingtons Disease > Phosphate
The following information is about Phosphate.
Phosphate Defined
One of the molecular components of a nucleotide; a small molecule made up of phosphorus and oxygen.
This definition is in context to Huntingtons Disease. See more contextual defintions for Phosphate.
Salix Presents New Phase II Data Evidence Demonstrating the Clinical Utility of Rifaximin in Irritable Bowel Syndrome ...
Published October 6, 2008, 6:18 am, Centre Daily Times
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced findings from two analyses of a Phase II clinical trial that demonstrate the utility of rifaximin, a non-absorbed, gut-selective antibiotic, in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS). Data presented at the annual meeting of the American College of Gastroenterology (ACG) showed that patients ...
Salix Presents New Phase II Data Evidence Demonstrating the Clinical Utility of Rifaximin in Irritable Bowel Syndrome ...
Published October 6, 2008, 6:00 am, Business Wire via Yahoo! Finance
ORLANDO, Fla.----Salix Pharmaceuticals, Ltd. today announced findings from two analyses of a Phase II clinical trial that demonstrate the utility of rifaximin, a non-absorbed, gut-selective antibiotic, in the treatment of patients with diarrhea-predominant irritable bowel syndrome .
Rifaximin Demonstrates Highly Statistically Significant Results in Prevention of Hepatic Encephalopathy in Pivotal ...
Published October 6, 2008, 4:16 am, Centre Daily Times
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the successful completion and outcome of its pivotal Phase 3 trial to evaluate the efficacy, safety and tolerability of rifaximin in preventing hepatic encephalopathy, or HE. This study demonstrates that the protocol-specified, intent-to-treat, primary endpoint comparison of a 6-month course of rifaximin at 550 mg dosed twice-a-day ...
Rifaximin Demonstrates Highly Statistically Significant Results in Prevention of Hepatic Encephalopathy in Pivotal ...
Published October 6, 2008, 4:00 am, Business Wire via Yahoo! Finance
RALEIGH, N.C.----Salix Pharmaceuticals, Ltd. today announced the successful completion and outcome of its pivotal Phase 3 trial to evaluate the efficacy, safety and tolerability of rifaximin in preventing hepatic encephalopathy, or HE.
Atmore recognized for fluoride quality
Published October 5, 2008, 1:12 am, The Atmore Advance
Atmore Utilities Board water superintendent John Roley and operator Reddick English show off the Fluoridation Quality Award.
Environment: Pollution slowly killing world's coral reefs
Published October 2, 2008, 8:16 am, BusinessWorld Online
CANCUN, MEXICO — Dainty blue fish dart around coral shaped like moose antlers near the Mexican resort of Cancun, but sickly brown spots are appearing where pollution threatens one of the world's largest reefs.
Alimera Reports Results From The Six-Month Interim Readout Of The Human PK Iluvien(TM) Study
Published October 2, 2008, 3:06 am, Medical News Today
Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, reported the interim month six safety and efficacy results from the first human pharmacokinetic (PK) study of Iluvien(TM).
Californians Have Toxic Flame Retardants in Their Blood at Levels Twice the National Average, According to New ...
Published October 1, 2008, 7:18 am, PR Newswire via Yahoo! Finance
People and homes in California have been found to have significantly higher levels of toxic flame retardants called polybrominated diphenyl ethers , compared to other locations in the country and the world.
Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
Published October 1, 2008, 5:00 am, PR Newswire via Yahoo! Finance
Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported the interim month six safety and efficacy results from the first human pharmacokinetic study of Iluvien.
OXiGENE Announces Strategic Collaboration With Symphony Capital
Published September 30, 2008, 11:00 pm, GlobeNewswire via Yahoo! Finance
WALTHAM, Mass., Oct. 1, 2008 -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, has entered into a strategic collaboration with Symphony Capital Partners, L.P. that will provide OXiGENE with up to $40 million to further advance its pipeline of vascular disrupting agent drug candidates for cancer and eye disease.
Are you looking for additional Huntingtons Disease > Phosphate news? Try our new "Phosphate News Focus" area.
Off-site Phosphate Links, User Submitted
The following links have been collected through user bookmark submission in the Phosphate category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Sat Oct 4
Wed Oct 1
Tue Sep 30
Mon Sep 29
Mon Sep 22
Tue Sep 9
- Polymer Aids In Blood Clotting, Pointing Way To New Treatment: polymer aids in blood clotting
Sun Aug 31
Tue Aug 12
- Guanidine Hydrogen Phosphate-Base d Flame-Retardan t Formulations for Cotton -- Vroman et al. 34 (1): 27 -- Journal of Industrial Textiles
- ScienceDirect - Journal of Analytical and Applied Pyrolysis : Flame retardance of wood treated with guanidine compounds characterized by thermal degradation behavior
Fri Aug 8
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Phosphate. If you would like to find related tags we recommend Tag Patterns > Phosphate
Off-site Phosphate Research Links
If you still need additional information on Phosphate then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Huntingtons Disease Topics
Everything you need to know about Huntingtons Disease
Huntingtons Disease
If you know the Huntingtons Disease Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Huntingtons-Disease.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.